Indication
Prevent extracorporeal clotting during hemodialysis
This clinical indication refers to the prevention of thrombosis within the artificial bloodlines and dialyzer membranes of an external dialysis circuit during renal replacement therapy. Read more about Prevent extracorporeal clotting during hemodialysis
45 drugs 23 manufacturers
Drugs that treat it
Common Prevent extracorporeal clotting during hemodialysis therapies.
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM (heparin sodium,porcine)
HEPARIN SODIUM-0.45% NACL (heparin sodium,porcine in 0.45 % sodium chloride)
HEPARIN SODIUM IN 0.45% NACL (heparin sodium,porcine in 0.45 % sodium chloride)
HEPARIN SODIUM IN 0.45% NACL (heparin sodium,porcine in 0.45 % sodium chloride)
HEPARIN SODIUM-0.45% NACL (heparin sodium,porcine in 0.45 % sodium chloride)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonThis clinical indication refers to the prevention of thrombosis within the artificial bloodlines and dialyzer membranes of an external dialysis circuit during renal replacement therapy.
The target population comprises individuals with acute kidney injury or end-stage kidney disease undergoing intermittent or continuous hemodialysis.
Extracorporeal clotting is triggered when patient blood contacts synthetic, non-endothelial surfaces, combined with turbulence, air exposure, and shear stress, which activate the intrinsic coagulation cascade and stimulate platelet adhesion and aggregation.
Without appropriate prophylactic intervention, this state leads to premature circuit occlusion, diminished clearance of toxins and fluids, procedural interruption, and clinically significant blood loss.
- hpplines.com
This clinical indication refers to the prevention of thrombosis within the artificial bloodlines and dialyzer membranes of an external dialysis circuit during renal replacement therapy
- ovid.com
This clinical indication refers to the prevention of thrombosis within the artificial bloodlines and dialyzer membranes of an external dialysis circuit during renal replacement therapy The target population comprises individuals with acute kidney injury or end-stage kidney disease undergoing intermittent or continuous hemodialysis Extracorporeal clotting is triggered when patient blood contacts synthetic, non-endothelial surfaces, combined with turbulence, air exposure, and shear stress, which a...
- nih.gov
The target population comprises individuals with acute kidney injury or end-stage kidney disease undergoing intermittent or continuous hemodialysis
- ekpf.eu
Without appropriate prophylactic intervention, this state leads to premature circuit occlusion, diminished clearance of toxins and fluids, procedural interruption, and clinically significant blood loss
- wls-dialysis.com
Without appropriate prophylactic intervention, this state leads to premature circuit occlusion, diminished clearance of toxins and fluids, procedural interruption, and clinically significant blood loss
Personalize your experience
Follow Prevent extracorporeal clotting during hemodialysis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.